By Kevin Stawicki ( March 20, 2019, 7:01 PM EDT) -- A regulatory change in 2016 didn't require the Centers for Medicare & Medicaid Services to retroactively reclassify STI Pharma LLC's antibiotic Sulfatrim as a "non-innovator" generic that carried a lower rebate rate for the drugmaker, the Department of Health and Human Services has told a federal court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.